Derek Jantz

Derek Jantz has extensive work experience in the field of scientific research and development. Derek has held various leadership positions at different companies throughout their career.

In 2006, Derek joined Precision BioSciences as the Chief Scientific Officer and remained in this role until February 2023. During their time at Precision BioSciences, they played a crucial role in driving scientific innovation and overseeing the company's research and development efforts.

In February 2023, Derek transitioned to the role of Chief Science Advisor at Precision BioSciences, Inc. Derek provided strategic guidance and scientific expertise to the company in this position.

More recently, in April 2023, Derek joined Tune Therapeutics as the Chief Scientific Officer. In this role, they are responsible for leading scientific research and development efforts to advance the company's mission.

Overall, Derek Jantz's work experience showcases their expertise and contributions to the field of scientific research and development, particularly in the areas of genetic engineering and therapeutic technologies.

Derek Jantz has a strong educational background in the field of science. Derek began their academic journey in 1993 at the University of Colorado Boulder, where they pursued a Bachelor of Arts degree in Biology. After completing their undergraduate studies in 1996, they went on to attend The Johns Hopkins University School of Medicine from 1997 to 2003. During this time, they earned a Doctor of Philosophy degree (PhD) with a focus on Biophysics and Biophysical Chemistry.

Following their doctoral studies, Derek Jantz joined Duke University for a Postdoctoral Fellowship from 2003 to 2006. Their fellowship at Duke concentrated on Biochemistry, further expanding their expertise in the realm of scientific research and analysis.